Tara Bancroft
Stock Analyst at TD Cowen
(2.73)
# 2,068
Out of 5,008 analysts
9
Total ratings
57.14%
Success rate
26.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $52.70 | +51.80% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $36.76 | +36.02% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $64.14 | +1.34% | 1 | Sep 24, 2024 | |
| OCUL Ocular Therapeutix | Upgrades: Buy | $7 → $11 | $10.97 | +0.27% | 3 | Jun 20, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.28 | +681.25% | 1 | Apr 29, 2024 | |
| MRUS Merus | Initiates: Outperform | n/a | $94.27 | - | 1 | Aug 21, 2023 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $8.23 | - | 1 | Aug 31, 2022 |
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $52.70
Upside: +51.80%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $36.76
Upside: +36.02%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $64.14
Upside: +1.34%
Ocular Therapeutix
Jun 20, 2024
Upgrades: Buy
Price Target: $7 → $11
Current: $10.97
Upside: +0.27%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.28
Upside: +681.25%
Merus
Aug 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $94.27
Upside: -
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $8.23
Upside: -